Zai Lab
NASDAQ: ZLABFounded 2014 · Incorporated in Cayman Islands · 537 employees on LinkedIn · 3 known investors
Zai Lab is a global biopharmaceutical company developing and commercializing therapies in oncology, immunology, neuroscience, and infectious disease, with operations in China and the United States. The company combines in-licensed assets with internal R&D capabilities and has eight marketed products in China.
Founders & leadership
Zai Lab was founded in 2014 by Samantha Du.
SD
Samantha Du
Investors · 3
In the news
Frequently asked questions
- What does Zai Lab do?
- Zai Lab is a global biopharmaceutical company developing and commercializing therapies in oncology, immunology, neuroscience, and infectious disease, with operations in China and the United States. The company combines in-licensed assets with internal R&D capabilities and has eight marketed products in China.
- Who founded Zai Lab?
- Zai Lab was founded by Samantha Du in 2014.
- Who are Zai Lab's investors?
- Zai Lab's investors include Qiming Venture Partners, Vivo Capital, YuanBio Venture Capital.
- Where is Zai Lab headquartered?
- Zai Lab is headquartered in Unknown, CN.


